CareLit CareLitFachliteratur für Gesundheitsberufe
CareLit · DOI-Nachweis · Pneumologie

Modeling Cystic Fibrosis in vitro: A new possible platform for patient customised drug screening and ex-vivo gene therapy?

R Haller, S Ulrich, S Weinreich, S Merkert, C Bednarski, C Mauritz, U Martin · Pneumologie · Ausgabe 06/2014

DOI 10.1055/s-0034-1376824

Bibliografische Angaben

Nachweis in CareLit

Autor:innenR Haller, S Ulrich, S Weinreich, S Merkert, C Bednarski, C Mauritz, U Martin
ZeitschriftPneumologie
Ausgabe06/2014
Jahrgang / SeitenNicht angegeben

Kernaussage aus der Literatur

Abstract-Vorschau

Cystic fibrosis (CF) is the most common lethal monogenic recessive disease in the caucasian population. Over 1900 mutations are known in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene, but the most common mutation is the F508del resulting in misfolding of the CFTR protein. Until today, classical gene therapy trials have not been successful in CF patients, and currently approved CFTR modulators a…

Zitieren

Zitierempfehlung

R Haller, S Ulrich, S Weinreich, S Merkert, C Bednarski, C Mauritz, U Martin (2014) Modeling Cystic Fibrosis in vitro: A new possible platform for patient customised drug screening and ex-vivo gene therapy?. Pneumologie (06). https://doi.org/10.1055/s-0034-1376824

Mit CareLit weiterarbeiten

Volltext, Abstract und ähnliche Literatur